More people die from blood clots than breast cancer, car accidents and AIDs combined. INRTracker.com is helping those at risk.INTRTracker was born out of the love co-founders Veronica Coulombe and Pavan Katepalli share. The site helps people on blood thinners manage their health by keeping track of their diet as well as generating easy-to-read reports for their doctor.
In, 2012 Coulombe, a front end developer, got a Deep Vein Thrombosis (DVT) blood clot in her leg and a Pulmonary Embolism (PE) in her lung. When it hit, she felt horrible pain.
While one-sixth of people who get a DVT/PE die, Coulombe survived. She found out she had Factor V Leiden: a genetic clotting disorder, and she was homozygous (both her chromosomes have it) for the disease. 100 percent of people who are homozygous get a blood clot.
To dissolve the clots and prevent future clots, her doctor prescribed her Warfarin, a common blood thinner. Coulombe later met Katepalli and their friendship blossomed into love. However, Coulombe’s health held them back from experiencing true happiness.
While on Warfarin, if Veronica faltered in diet, especially vitamin K, her Warfarin could either be intensified or lessoned and she could die from either bleeding to death or from blood clots. In addition, Veronica had to go to the doctor weekly to get a special blood test to see if her dosage was effective, called an INR Test.
As her boyfriend, Katepalli felt her pain. So he built an application to let Coulombe log her data to generate reports for her doctor. Coulombe was able to plan her meals out using the application and better understand Vitamin K and the other factors affecting her health.
As a front-end developer Coulombe saw the potential in the application, so she helped bring the application to the web as INRTracker. INRTracker has raised funds from a Houston-based biotech company, ReliantHeart Inc. (www.reliantheart.com). ReliantHeart is led by serial entrepreneur Rodger Ford.
In the past, Ford has led small companies to success. With Syncardia Systems Inc. Rodger led them to FDA approval and Medicare/Medicaid reimbursement of their Artificial Heart Technology, as well as $50 million plus in venture funding.
“It’s been my dream to run a start-up and make a difference in the world. Doing that with Veronica is unreal. She’s my best friend and the best co-founder I’ve ever had,” said Katepalli.
INRTracker’s users have made over 41,000 logs.
“It allows me to calculate my average Vitamin K intake for the week allowing me to enjoy small salads and some green food again! I am excited about the new dashboard, which will provide me additional ways to track my medications, blood pressure ranges and other helpful information for my doctor. Instead of testing every week or every two weeks I am now able to test once a month and in the future will be able to test every three months,” said Shauna Christine said about the site.
Now, people on Warfarin can relax and enjoy the holiday because they’ll be able to manage their Warfarin Therapy and Vitamin K on INRTracker.com. The site also provides a comprehensive vitamin k food database and custom Coumadin diet guide.
- Each year in the U.S. 300,000 to 600,000 people experience blood clots.
- 60,000 to 100,000 Americans die each year from DVTs and PEs.
- That’s twice as many deaths from breast cancer and three times as many deaths from car accidents.
- Warfarin is the most commonly prescribed anticoagulant medicine on the market. It is prescribed to patients who have suffered from a DVT/PE.
- Warfarin is ranked first in number of deaths for drugs causing "adverse effects in therapeutic use", beating out Insulin.
- In the U.S. 20 million people are prescribed Warfarin, with two million new patients being prescribed Warfarin every year.